Basic problem and objective: In rare instances Pneumocystis carinii pn
eumonia (PCP) can occur in a cystic form, characterized by an acute co
urse. The correct diagnosis is often missed. An analysis of a large co
hort of patients with PCP was undertaken to determine the incidence an
d clinical manifestations of this form of the disease. Patients and me
thods: Data on all HIV-positive patients on the hospital registry, hos
pitalized with the diagnosis of PCP between January 1988 and July 1996
, were retrospectively analysed. To be included in the study, PCP had
to have been confirmed microscopically on bronchial ravage or histolog
ically by lung biopsy. The chest radiogram and (if available) computed
tomogram of these patients were examined for possible cystic changes,
and clinical as well as laboratory findings recorded. Results: Five o
f 180 patients with PCP had cystic changes (2.8%). The interval betwee
n first symptoms and diagnosis ranged from 30 to 200 days (median: 32
days). All five patients (age: 24-49 years; all males) had a far advan
ced immunological disorder (median CD4 count: 10/mu l) and were in sta
ge C3 (Centers for Disease Control). Three of the five patients had pr
ophylactically inhaled pentamidine (300 mg/month). Bronchial lavage wa
s false-negative in three of the five cases. One patient had a spontan
eous pneumothorax. Lactate dehydrogenase levels were normal or only sl
ightly elevated (207-417 U/l; median 305 U/l). Both the cavities and t
hin-walled cysts were demonstrated radiologically, but were more visib
le on CT than on the X-ray film. All patients responded well to the me
dication with cotrimoxazole, but the prognosis was poor with a surviva
l time of only 0.3 to 16 months. Conclusion: PCP should be included in
the differential diagnosis when HIV patients have cystic lung changes
. Invasive diagnostic methods are often required to avoid wrong diagno
sis and superfluous therapeutic interventions.